Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
110.73B | 112.79B | 112.04B | 105.16B | 98.82B | 92.94B | Gross Profit |
15.36B | 15.07B | 17.14B | 15.23B | 15.08B | 14.02B | EBIT |
388.00M | 552.00M | 2.39B | 694.00M | 1.11B | 710.00M | EBITDA |
5.73B | 6.92B | 10.50B | 8.41B | 9.00B | 8.37B | Net Income Common Stockholders |
-3.15B | -4.19B | 1.75B | 399.00M | 621.00M | 300.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
19.01B | 19.95B | 21.11B | 16.95B | 20.25B | 21.31B | Total Assets |
117.94B | 122.34B | 119.46B | 113.77B | 114.38B | 113.73B | Total Debt |
26.18B | 26.11B | 22.68B | 22.81B | 25.46B | 28.34B | Net Debt |
7.17B | 6.16B | 1.57B | 5.86B | 5.21B | 7.03B | Total Liabilities |
49.05B | 53.05B | 46.87B | 46.69B | 48.08B | 49.39B | Stockholders Equity |
68.20B | 68.67B | 72.01B | 66.58B | 65.79B | 63.73B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.82B | 4.62B | 200.00M | 2.49B | 559.00M | Operating Cash Flow |
0.00 | 6.25B | 10.74B | 5.87B | 7.10B | 5.64B | Investing Cash Flow |
0.00 | -10.20B | -6.22B | -5.84B | -4.72B | -5.13B | Financing Cash Flow |
0.00 | 2.07B | -1.01B | -4.03B | -3.73B | 8.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.60B | 4.45 | 5.59% | 1.49% | 93.90% | ||
76 Outperform | ¥24.20B | 7.05 | 6.51% | 0.36% | 242.74% | ||
74 Outperform | ¥15.77B | 7.21 | 2.90% | -5.40% | ― | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
53 Neutral | ¥8.14B | ― | 2.79% | -3.96% | -462.49% | ||
52 Neutral | ¥17.90B | ― | 3.24% | 0.66% | -340.28% | ||
48 Neutral | ¥21.23B | ― | 3.53% | -1.68% | -240.66% |